Bausch Health
212 hedge funds and large institutions have $1.64B invested in Bausch Health in 2025 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 61 increasing their positions, 64 reducing their positions, and 43 closing their positions.
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
4% more capital invested
Capital invested by funds: $1.58B → $1.64B (+$61.9M)
0.28% more ownership
Funds ownership: 66.3% → 66.58% (+0.28%)
5% less repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 64
8% less funds holding
Funds holding: 230 → 212 (-18)
37% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 43
73% less call options, than puts
Call options by funds: $14.4M | Put options by funds: $53.4M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Paulson & Co
New York
|
+$32.6M |
| 2 |
GAM
Goldentree Asset Management
New York
|
+$20.6M |
| 3 |
MSE
MUFG Securities EMEA
London,
United Kingdom
|
+$17.5M |
| 4 |
SG Americas Securities
New York
|
+$16.9M |
| 5 |
MRCP
Maple Rock Capital Partners
Toronto,
Ontario, Canada
|
+$5.19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$16.5M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$13.2M |
| 3 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
-$10.8M |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
-$9.76M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$7.71M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CWM
251
Cranbrook Wealth Management
Bloomfield Hills,
Michigan
| – | -$1.24K | -192 | Closed |
|
|
HFS
252
Hantz Financial Services
Southfield,
Michigan
| – | -$1K | -178 | Closed |
|
253
Amundi
Paris,
France
| – | -$862 | -152 | Closed |
|
|
SAM
254
Smartleaf Asset Management
Boston,
Massachusetts
| – | -$479 | -74 | Closed |
|
|
SW
255
SVB Wealth
Boston,
Massachusetts
| – | -$149 | -23 | Closed |
|
BHC Hedge Fund Activity: Q2 2025 in Review
212 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q2 2025, worth a combined $1.64B — up 3.9% from $1.58B a quarter earlier.
Sellers outnumbered buyers: 43 funds closed out of BHC and 27 opened new positions — a net loss of 16 holders — while 64 trimmed existing stakes and 61 added.
The largest buyer was Paulson & Co, adding an estimated $32.6M. The largest seller was Franklin Resources, cutting an estimated $16.5M.
- 212 institutional investors held Bausch Health (BHC) as of Q2 2025, down from 230 in Q1 2025.
- Funds reported $1.64B of Bausch Health stock for Q2 2025, up 3.9% quarter-over-quarter.
- 27 funds opened new Bausch Health positions in Q2 2025 and 43 closed out, a net change of -16 holders.
- The largest Bausch Health buyer in Q2 2025 was Paulson & Co, an estimated $32.6M added.
- The largest Bausch Health seller in Q2 2025 was Franklin Resources, an estimated $16.5M sold.
Based on aggregated 13F filings for Q2 2025.